Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

NCT04755777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2023-02-21

No results posted yet for this study

Summary

The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Erin Barreto, Pharm. D.,R.Ph. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04755777 on ClinicalTrials.gov